Growth Hormone Market size worth $ 6.22 Billion, Globally, by 2028 at 6.70% CAGR: Verified Market Research®

JERSEY CITY, N.J., Oct. 25, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Growth Hormone Market" By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Route of Administration (Intravenous, Subcutaneous, Intramuscular), and By Geography. According to Verified Market Research, the Global Growth Hormone Market size was valued at USD 3.68 Billion in 2020 and is projected to reach USD 6.22 Billion by 2028, growing at a CAGR of 6.70% from 2021 to 2028.

Verified_Market_Research_Logo

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=10968

Browse in-depth TOC on "Growth Hormone Market"

202 - Pages
126 – Tables
37 – Figures

Global Growth Hormone Market Overview

The demand for the Growth Hormone market is growing at a rapid pace, mainly due to increasing cases of pituitary dysfunction leading to deficiency of the growth hormone. According to the statistics revealed by Oregon Health & Science University growth hormone deficiency is rare however, it affects around 50,000 U.S. adults. The higher or lower level of human growth hormone impacts the growth of the individuals, wherein the low level shows the risk of higher amount fat accumulation throughout the body and increased level lead to various medical conditions such as gigantism, acromegaly, muscle-wasting disease, and short bowel syndrome.

Increasing awareness regarding the treatment of growth hormone deficiency is the prominent factor, driving the growth of the growth hormone market. Large pharmaceutical companies are continuously conducting research and development activities in combination with trials for the development of novel therapies, which is projected to push the growth of the growth hormone market. Companies are introducing new therapies and treatments to maintain the GH level of the affected individuals.

For instance, in August 2020, U.S. Food and Drug Administration (US FDA) approved Novo Nordisk, Inc.'s Sogroya (somapacitan), as the first human growth hormone (HGH) therapy that adult patients only take once a week by injection under the skin. In addition to this, favourable support by the government of various countries to promote awareness regarding GH is pushing the market growth.

Key Developments in Growth Hormone Market

  • In September 2021, Biocorp and Merck joined hands for the development and global distribution of a specific version of the Mallya device for applications in the field of HGH.
  • In August 2020, U.S. Food and Drug Administration (US FDA) approved Novo Nordisk, Inc.'s Sogroya (somapacitan), as a first human growth hormone (HGH) therapy that adult patients only take once a week by injection under the skin.

The major players in the market are Anhui Anke Biotechnology Group Co., Ltd, Biopartners GmbH, Eli Lilly and Company, GeneScience Pharmaceuticals Co., Ltd, Ipsen S.A., Merck KgaA, Novartis AG, Novo Nordisk A/S, Pfizer Inc., and Roche Holdings, Inc.

Verified Market Research has segmented the Global Growth Hormone Market On the basis of Application, Distribution Channel, Route of Administration, and Geography.

  • Growth Hormone Market, By Application
    • Growth Hormone Deficiency
    • Turner Syndrome
    • Idiopathic Short Stature
    • Prader-Willi Syndrome
    • Others
  • Growth Hormone Market, By Distribution Channel
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
    • Clinics
  • Growth Hormone Market, By Route of Administration
    • Intravenous
    • Subcutaneous
    • Intramuscular
    • Oral
  • Growth Hormone Market by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany 
      • France
      • U.K
      • Rest of Europe
    • o Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Biosimilar Monoclonal Antibodies (mAbs) Market By Product (Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte- Colony Stimulating Factor (G-CSF)), By Application (Anti-Cancer and Anti-Inflammatory/Autoimmune), By Geography, Forecast, 2021-2028

Compounding Pharmacy Market By Product (Oral medications, Topical medications, Suppositories), By Therapeutic Area (Hormone replacement therapies, Pain medications, Dermatological applications), By Geography, Forecast, 2021-2028

Bioidentical Hormones Market By Product Type (Tablets & Capsules, Creams & Gels, Injectables, Patches & Implants, Others), By Type (Estrogen's, Progesterone, Testosterone, Others), By Geography, Forecast, 2021-2028

Hormonal Contraceptive Market By Product (Oral Contraceptives, Skin Patches, Intrauterine Devices), By Harmone (Progestin Only, Combined Hormone Contraceptives), By Geography, Forecast, 2021-2028

Top 10 human growth hormone companies treating growth hormone deficiency

Visualize Growth Hormone Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter 

Cision View original content:https://www.prnewswire.com/news-releases/growth-hormone-market-size-worth--6-22-billion-globally-by-2028-at-6-70-cagr-verified-market-research-301407436.html

SOURCE Verified Market Research

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.